Compare CI & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CI | NTES |
|---|---|---|
| Founded | 1792 | 1997 |
| Country | United States | China |
| Employees | N/A | 25382 |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.0B | 76.5B |
| IPO Year | 2018 | N/A |
| Metric | CI | NTES |
|---|---|---|
| Price | $275.92 | $130.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $349.00 | $160.00 |
| AVG Volume (30 Days) | ★ 1.8M | 868.9K |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | 2.13% | ★ 2.61% |
| EPS Growth | ★ 83.00 | N/A |
| EPS | ★ 12.55 | N/A |
| Revenue | ★ $274,900,000,000.00 | N/A |
| Revenue This Year | $5.91 | $9.57 |
| Revenue Next Year | $5.92 | $8.57 |
| P/E Ratio | ★ $21.55 | $79.88 |
| Revenue Growth | ★ 11.24 | N/A |
| 52 Week Low | $239.51 | $106.06 |
| 52 Week High | $315.47 | $159.55 |
| Indicator | CI | NTES |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 52.69 |
| Support Level | $266.69 | $128.99 |
| Resistance Level | $277.24 | $135.97 |
| Average True Range (ATR) | 7.50 | 2.04 |
| MACD | -2.35 | 0.03 |
| Stochastic Oscillator | 22.76 | 64.52 |
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.